相关实验视频
Updated: Jan 17, 2026

09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
16.5K
基于专蛋白的纳米颗粒药物输送系统的最新进展用于治疗肠道疾病
Xianrui Lin1,2, Lin Wang1, Zhihao Lin1,2
1State Key Laboratory of Resource Insects, Southwest University, Chongqing 400715, China.
International journal of pharmaceutics: X
|September 22, 2025
概括
专纳米颗粒 (ANP) 为治疗炎症性肠病 (IBD) 和结肠直肠癌 (CRC) 等肠道疾病提供了一个有前途的方法. 这些ANP可以提高药物输送和疗效,同时最大限度地降低毒性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 胃肠病学 胃肠病学
背景情况:
- 肠道疾病,包括炎症性肠病 (IBD) 和结直肠癌 (CRC),由于复杂的病理和治疗限制,造成了重大管理挑战.
- 目前的疗法往往受到药物向和全身毒性不良的影响,需要创新的输送系统.
研究的目的:
- 审查基于素纳米粒子 (ANP) 治疗肠道疾病的进展.
- 突出ANP制造方法和利用疾病特异性病理特征的准策略.
- 讨论ANP在IBD和CRC的精确治疗方面的潜力.
主要方法:
- 总结关键的ANP制造方法.
- 专注于被动准策略,利用泄漏的血管系统,酸性pH值和肠道疾病微环境中的氧化应激.
- 通过受体介导机制详细介绍积极准的修改.
主要成果:
- 在IBD和CRC的临床前模型中,药物载荷的ANP显示了增强的局部药物积累.
- 服用ANP导致抑制炎症,改善治疗效果.
- 利用病理特征和积极准机制改善了ANP的性能.
结论:
- 专纳米颗粒 (ANP) 显示出作为肠道疾病药物输送平台的显著前景.
- 可以设计ANP以提供有针对性的治疗,从而提高IBD和CRC的治疗结果.
- 尽管在口服和扩展方面存在挑战,但ANP是精确治疗肠道疾病的可行策略.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
188
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
188
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200

